ObvioGo 2.0
Remote Study Participation
About
This application facilitates clinical trial participation remotely, allowing users to complete study tasks, provide consent, and communicate with study teams from home. It's part of a decentralized clinical trial platform designed for ease and convenience.
What's New in ObvioGo 2.0
2.6.5
June 8, 2026
Bug Fixes and Feature Enhancements
Developer apps
FAQ
What is ObvioGo 2.0 used for?
ObvioGo 2.0 is a mobile application designed to make clinical trial participation easier and more seamless. It allows participants to engage in studies remotely, from home, by completing tasks, providing consent, and communicating with their study team.
Is ObvioGo 2.0 free to use?
Yes, ObvioGo 2.0 is available for free. The provided data indicates the app is free with no mention of in-app purchases or subscriptions.
What devices does ObvioGo 2.0 support?
ObvioGo 2.0 is supported on iPhone, iPad, and iPod devices. It is designed for use on Apple's iOS operating system.
How often is ObvioGo 2.0 updated?
The latest version of ObvioGo 2.0 is 2.5.2, which was last updated on January 21, 2026. This indicates a recent update, suggesting the app is actively maintained.
What is the age rating for ObvioGo 2.0?
ObvioGo 2.0 has an age rating of 17+. This is based on the app's content and suitability for mature users.
Does ObvioGo 2.0 have ads?
No, ObvioGo 2.0 does not contain advertisements. The app's data indicates it is ad-free.
What are the key features of ObvioGo 2.0 for clinical trial participants?
Key features include the ability to provide digital consent, complete study-specific tasks, report changes in health or medication, and communicate directly with the clinical study team, all from a personal device.
What is the user sentiment for ObvioGo 2.0 based on ratings?
Based on the available rating, ObvioGo 2.0 has received a perfect 5.0 stars from one rating. This suggests a highly positive initial user experience.
